One possibility is that bone mass loss in MR mice on HFD is associated with increased levels of FGF21, a hepatokine shown to reverse obesity and type 2 diabetes [9] via Pparγ signaling mechanisms [10]. Here, FGF21 is linked to type 2 diabetes mellitus.